Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2022: Advantages Offered, by Non-invasivene Approach, by CTC & Growing Awareness About the Novel Diagnostic Methods for Cancers

News provided by

Mar 11, 2022, 05:45 ET

DUBLIN, March 11, 2022 /PRNewswire/ -- The "Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The scope of this study involves clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment as well as currently approved CTC tests and their markets.

By cancer type, the global market for circulating tumor cells diagnostics has been segmented into breast cancer, colorectal cancer and prostate cancer. The fast growth rate of the colorectal cancer segment is attributed to rapid rise in the incidence of colorectal cancer, especially young adults.

The growing prevalence of cancer, as circulating tumor cells find their applications in the diagnosis of cancer and precision management; advancements in technologies such as NGS and immunofluorescence; and growing awareness about the novel diagnostic methods for cancers are all major factors that will boost market growth.

Reasons for Doing this Study

This study was conducted to provide detailed information regarding new developments, prognostic and clinical research testing for circulating tumor cells. There is an increasing need for new and innovative technologies in this area. This industry is experiencing tremendous growth; the use of new prognostic technologies based on circulating tumor cells has increased in the past few years.

This study will increase awareness of current and emerging technologies and practices for cancer and cancer research, especially for prostate, breast and colorectal cancers.

The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share, along with the latest trends and new developments in this area, are included to support the clinical testing market.

This report discusses some of the major drivers and restraints in the market for circulating tumor cells diagnostics, and it surveys the competitive landscape as well as the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions.

The report also includes company profiles of major vendors that include a company overview, key product offerings, financial statistics and recent developments. The report provides insights on market shares and upcoming regional demand for circulating tumor cells diagnostics.

Some of the major market players discussed in the report are Qiagen N.V., Biocept Inc., Greiner Bio One International GmbH, Precision Medicine Group LLC and Menarini Silicon Biosystems.

For market estimates, data have been provided for the 2020 as the base year, with forecasts for 2021 through 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes

An up-to-date review and analysis of the global markets for circulating tumor cell (CTC) diagnostics
Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
Highlights of the upcoming market opportunities in the CTC diagnostics industry, and areas of focus to forecast this market into various segments and sub-segments
Evaluation and forecast the global CTC diagnostics market size, forecasted growth trends, and corresponding market share analysis by cancer type, technology, application, and region
In-depth information concerning market drivers and challenges, latest technologies, breakthrough innovations, costs and benefits of CTC enrichment techniques, regulatory concerns, and clinical trials
Statistical information (facts and figures) on cancer incidence and prevalence, global cancer related deaths, and new cases of cancer by type in the United States
Review of recent industry trends, value chain analysis, competitive landscape, and COVID-19 implications within the marketplace
Descriptive company profiles of the leading global players, including Bio-Techne Corp., Biocept Inc., Greiner Bio-One International GmbH, Precision Medicine Group LLC, Menarini Silicon Biosystems, and Qiagen N.V.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Cancer
Recent Advances in Technology
Invasive Power
Circulating Tumor Cells
Phenotypic Characteristics
CTC Clusters
CTC Detection
Cancer Stem Cells (Cscs)
Circulating Tumor Cells - Potential Uses
Proliferative Activity
Epithelial Marker Genes on Circulating Tumor Cells
Circulating Tumor Cells and Stem Cell-Like Phenotype
CTCs and Primary Tumor Cells: a Comparison
Metastasis
Future Directions
Metastatic Development in Cancer Patients
Circulating Tumor Cell Migration
Circulating Tumor Cell Detection
Methods
Cellsearch Method
Epic Sciences Method
Maintrac
Iset Test
Challenges for Detection
Clinical Application of Circulating Tumor Dna
Circulating Tumor Cells as Predictor of Response to Therapy
Measurement of CTCs - Applications
Conclusion

Chapter 4 CTC Diagnostic Technologies

Finding Circulating Tumor Cells
Why CTCs?
Current CTC Detection and Isolation Methods
New Technologies for Detection
Cancer Prognosis
Nucleic Acid-Based Methods
Clinical Testing
Summary
New Emerging Technologies

Chapter 5 Impact of Covid-19 on the CTC Diagnostics Market

Overview
Covid-19 and Cancer Screening
Impact of Covid-19 on Company Revenues

Chapter 6 Market Dynamics

Market Drivers
Rising Incidence of Cancer Worldwide
Advantages Offered, by Non-invasivene Approach, by Circulating Tumor Cells
Advancements in NGS and Immunofluorescence Technologies
Growing Awareness About the Novel Diagnostic Methods for Cancers
Market Restraints
High Costs of CTC Diagnostics
Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics
Market Opportunities
Circulating Tumor Cells as a Therapeutic Target
Competitive Landscape

Chapter 7 Market Breakdown by Cancer Type

Global Market for CTC Diagnostics by Cancer Type
Breast Cancer
Colorectal Cancer
Prostate Cancer

Chapter 8 Market Breakdown by Technology

Global Market for CTC Diagnostics by Technology
CTC Enrichment and Detection
CTC Direct Detection
CTC Analysis

Chapter 9 Market Breakdown by Application

Global Market for CTC Diagnostics by Application
Clinical/Liquid Biopsy
Research

Chapter 10 Market Breakdown by Region

Global Market for CTC Diagnostics by Region
North America
Europe
Asia-Pacific
Rest of World

Chapter 11 Company Profiles

Bio-Techne Corp. (Advanced Cell Diagnostics Inc.)
Biocept, Inc.
Biofluidica
Creatv Microtech Inc.
Fluxion Biosciences, Inc.
Greiner Bio-One International GmbH
Ikonisys, Inc.
Ivdiagnostics, Inc.
Menarini Silicon Biosystems (Formerly Veridex LLC)
Miltenyi Biotec
Precision Medicine Group LLC
Qiagen N.V.
Rarecells, Inc.
Screencell
Stemcell Technologies Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lft1bn

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets